Short Interest in Nutex Health Inc. (NASDAQ:NUTX) Declines By 63.7%

Nutex Health Inc. (NASDAQ:NUTX) was the recipient of a significant drop in short interest during the month of October. As of October 31st, there was short interest totalling 35,700 shares, a drop of 63.7% from the October 15th total of 98,300 shares. Based on an average daily volume of 74,100 shares, the days-to-cover ratio is currently 0.5 days. Approximately 1.2% of the shares of the company are short sold.

Insider Buying and Selling

In related news, CFO Jon Christian Bates purchased 1,350 shares of the business’s stock in a transaction that occurred on Thursday, August 22nd. The shares were acquired at an average price of $21.46 per share, with a total value of $28,971.00. Following the acquisition, the chief financial officer now owns 2,277 shares in the company, valued at approximately $48,864.42. This trade represents a 145.63 % increase in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 38.52% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Nutex Health

Institutional investors have recently modified their holdings of the stock. Essex Investment Management Co. LLC bought a new position in Nutex Health during the third quarter valued at approximately $1,579,000. Thompson Davis & CO. Inc. bought a new position in shares of Nutex Health in the third quarter valued at approximately $494,000. State Street Corp acquired a new stake in shares of Nutex Health in the third quarter worth $225,000. Finally, International Assets Investment Management LLC bought a new stake in shares of Nutex Health during the 3rd quarter worth $188,000. Institutional investors and hedge funds own 5.32% of the company’s stock.

Nutex Health Stock Down 8.4 %

NASDAQ:NUTX traded down $2.63 during trading hours on Friday, hitting $28.70. 50,183 shares of the company’s stock traded hands, compared to its average volume of 42,760. The company has a debt-to-equity ratio of 3.36, a quick ratio of 1.55 and a current ratio of 1.77. The firm has a market cap of $156.13 million, a P/E ratio of -3.06 and a beta of 0.11. The stock’s fifty day moving average price is $23.52 and its two-hundred day moving average price is $14.22. Nutex Health has a twelve month low of $4.16 and a twelve month high of $39.48.

Analysts Set New Price Targets

A number of brokerages have issued reports on NUTX. Benchmark increased their price target on Nutex Health from $45.00 to $60.00 and gave the company a “buy” rating in a research note on Tuesday. Maxim Group lifted their target price on Nutex Health from $45.00 to $50.00 and gave the stock a “buy” rating in a report on Tuesday.

Nutex Health Company Profile

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.